Efficacy And Safety Of Abrocitinib In Adolescent Patients With Moderate-To-Severe Atopic Dermatitis (Ad): Results From The Phase 3 Jade Teen Study
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY(2021)